MedTrace Logo

Effect of Scoliosis and Progressive Resistance Exercises on Clinical and Pulmonary Parameters in Adolescents With Idiopathic Scoliosis

NCT07481279 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-04-06

No results posted yet for this study

Summary

Adolescent idiopathic scoliosis (AIS) is a common spinal deformity that may affect physical function and pulmonary capacity during adolescence. Exercise-based rehabilitation programs are frequently used in the conservative management of scoliosis.

The aim of this study is to investigate the effects of scoliosis-specific exercises combined with upper and lower extremity progressive resistance exercises on anthropometric, clinical, and pulmonary parameters in adolescents with idiopathic scoliosis.

Participants diagnosed with adolescent idiopathic scoliosis will participate in an exercise program including scoliosis-specific exercises and progressive resistance exercises targeting upper and lower extremities. Anthropometric measurements, clinical assessments, and pulmonary function parameters will be evaluated before and after the intervention.

The results of this study are expected to provide evidence regarding the effectiveness of combined exercise interventions on physical and respiratory outcomes in adolescents with idiopathic scoliosis.

Conditions

  • Adolescent Idiopathic Scoliosis (AIS)

Interventions

BEHAVIORAL

Scoliosis Exercises

Scoliosis-specific exercise program designed to improve spinal alignment, posture, and respiratory function in adolescents with idiopathic scoliosis. The program includes supervised therapeutic exercises performed under physiotherapist guidance.

BEHAVIORAL

Progressive Resistance Exercises

Progressive resistance exercise program targeting upper and lower extremity muscle groups including biceps, triceps, pectoral, back, quadriceps, and hamstring muscles.

Sponsors & Collaborators

  • Ankara City Hospital Bilkent

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2026-01-30
Completion
2026-01-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07481279 on ClinicalTrials.gov